| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 170.35B | 179.21B | 216.26B | 218.00B | 213.40B | 191.33B |
| Gross Profit | 23.04B | 23.74B | 26.84B | 19.22B | 22.67B | 19.28B |
| EBITDA | 15.16B | 15.97B | 21.09B | 14.27B | 19.86B | 12.31B |
| Net Income | 4.26B | 4.55B | 7.45B | 1.44B | 4.47B | -1.33B |
Balance Sheet | ||||||
| Total Assets | 174.31B | 168.41B | 185.61B | 199.63B | 208.33B | 189.18B |
| Cash, Cash Equivalents and Short-Term Investments | 45.54B | 42.76B | 49.16B | 33.70B | 42.07B | 34.05B |
| Total Debt | 4.04B | 1.17B | 3.56B | 6.58B | 10.44B | 10.33B |
| Total Liabilities | 56.31B | 56.86B | 75.79B | 102.21B | 113.36B | 103.42B |
| Stockholders Equity | 107.91B | 102.16B | 100.22B | 88.18B | 83.81B | 76.03B |
Cash Flow | ||||||
| Free Cash Flow | 5.74B | -135.00M | 18.79B | -354.00M | 6.21B | 8.17B |
| Operating Cash Flow | 11.92B | 3.82B | 22.35B | 4.06B | 12.14B | 16.15B |
| Investing Cash Flow | -5.88B | -3.48B | -3.10B | -2.81B | -3.95B | -8.69B |
| Financing Cash Flow | -1.69B | -6.49B | -6.63B | -7.68B | -2.79B | -625.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥265.89B | 7.94 | 12.15% | 2.87% | 3.95% | 136.86% | |
78 Outperform | ¥182.35B | 10.97 | ― | 1.03% | 3.62% | 3.64% | |
77 Outperform | ¥145.52B | 9.89 | ― | 3.30% | 0.29% | 9.87% | |
74 Outperform | ¥187.16B | 12.58 | ― | 4.47% | 2.01% | 25.09% | |
71 Outperform | ¥45.12B | 10.60 | ― | 2.37% | -13.35% | -19.38% | |
68 Neutral | ¥105.06B | 7.32 | ― | 3.88% | -7.35% | 43.31% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |